Premium Information is available for this item - Upgrade for $1 a day
6505-01-237-5382
Usp Cephalothin For Injection
6505012375382 012375382 SEFFIN NDC00173-0367-32
INC: 66667 Cephalothin For Injection
January 2023
5
Marketplace 6505-01-237-5382
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-237-5382 5+ Documents (More...)
6505-01-237-5382 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-237-5382
-6505/us 6505-01-237-5382 https https Usp Cephalothin For Injection 6505012375382 www.nsnlookup.com /
Usp Cephalothin For Injection 6505012375382 Cephalothin For Injection 6505012375382 0635 https
6505190010600 Injection 6505190010600 6505/br 6505-19-001-0600 https/ Cephalothin For Injection 6505012375382
Usp Cephalothin For Injection 6505012375382 Cephalothin For Injection 6505190010635 6505/us 6505
-01-207-6125 Usp Cephalothin For Injection Injection 6505012375382 Usp Cephalothin For Injection 6505012375382
Usp Cephalothin For Injection 6505012375382 5382 Usp Cephalothin For Injection 6505012375382 https
Injection 6505012076125 https https//www.nsnlookup.com www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-237-5382
6505-19 -001-0600 6505010129332 https https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-237-5382
Usp Cephalothin For Injection 6505012375382 Cephalothin For Injection 6505012076125 6505190010635 https
Restrictions 6505-01-237-5382
6505-01-237-5382 is a Usp Cephalothin For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-237-5382
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-237-5382
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-237-5382
- Part Number
- Manufacturer
- Status
- NDC00173-0367-32
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- SEFFIN
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-237-5382
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 1.000 Grams Cephalothin Equivalent
- Physical Form [AGXW]
- Powder
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Bottle, Infusion
- Primary Container Content Quantity [CRLK]
- 1.000 Grams Of Active Ingredient
- Total Primary Container Quantity [CSCW]
- 10
- Supplementary Features [SUPP]
- Medsep Item For Dod,Glaxo Inc
Management Data 6505-01-237-5382
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Apr 1987
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 10 Ea
- 00000000010EA
- K
Similar Supply Items to 6505-01-237-5382
Freight Information 6505-01-237-5382
6505-01-237-5382 has freight characteristics.. 6505-01-237-5382 has a variance between NMFC and UFC when transported by rail and the description should be consulted.